Through a series of in vitro and in vivo models simulating tumor progression and colorectal liver metastasis via intrasplenic injection of colon CT-26 and MC-38 cancer cells expressing apelin-dm, we unearthed compelling evidence of the anti-cancer and anti-angiogenic properties of apelin-dm. Here, APLN is linked to cancer.